Cites del registre

Cita APA (7th ed.)
Tang, T. C., Man, S., Xu, P., Francia, G., Hashimoto, K., Emmenegger, U., & Kerbel, R. S. (2010). Development of a Resistance-like Phenotype to Sorafenib by Human Hepatocellular Carcinoma Cells Is Reversible and Can Be Delayed by Metronomic UFT Chemotherapy. Elsevier.
Cita Chicago (17th ed.)
Tang, Terence C., Shan Man, Ping Xu, Giulio Francia, Kae Hashimoto, Urban Emmenegger, i Robert S. Kerbel. Development of a Resistance-like Phenotype to Sorafenib by Human Hepatocellular Carcinoma Cells Is Reversible and Can Be Delayed by Metronomic UFT Chemotherapy. Elsevier, 2010.
Cita MLA (9th ed.)
Tang, Terence C., et al. Development of a Resistance-like Phenotype to Sorafenib by Human Hepatocellular Carcinoma Cells Is Reversible and Can Be Delayed by Metronomic UFT Chemotherapy. Elsevier, 2010.
Atenció: Aquestes cites poden no estar 100% correctes.